Overview
SOLV market data
Price History
SOLV price chart · 1M
- O
- 90.81
- H
- 92.24
- L
- 90.81
- C
- 90.95
- Vol
- 37,927.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $90.81
- Previous Close
- $91.54
- Day High
- $92.24
- Day Low
- $90.81
- 52 Week High
- $92.71
- 52 Week Low
- $65.54
- 7 Day Return
- +2.59%
- 30 Day Return
- +5.58%
- 90 Day Return
- +21.33%
- 1 Year Return
- +36.75%
- Daily Notional Volume
- $3.4M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 10.26 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $8.88 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.45 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $62.38 – $92.71 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $14.7B · P/B 2.72 · P/S 1.77.
Company News
UBS Maintains Buy on Solventum, Raises Price Target to $101Benzinga · Aug 6, 2026, 6:52 PM
Solventum shares are trading lower after the company reported Q2 financial results. The stock initially rallied yesterday after the market closed, but it has since reversed.Benzinga · Aug 6, 2026, 6:30 PM
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105Benzinga · Aug 6, 2026, 4:46 PM
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101Benzinga · Aug 6, 2026, 3:44 PM
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102Benzinga · Aug 6, 2026, 2:41 PM
Stifel Maintains Buy on Solventum, Raises Price Target to $100Benzinga · Aug 6, 2026, 2:24 PM
BTIG Maintains Buy on Solventum, Raises Price Target to $95Benzinga · Aug 6, 2026, 9:49 AM
Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization StrategyBenzinga · Aug 5, 2026, 8:53 PM
Solventum shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.Benzinga · Aug 5, 2026, 8:42 PM
Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B EstimateBenzinga · Aug 5, 2026, 8:19 PM